银纳米粒子作为抗癌剂:机制洞察力,当前研究和局限性
Erkan Efe Okur1, Emir Akdaşçi1, Furkan Eker1
1Department of Molecular Biology and Genetics, Çanakkale Onsekiz Mart University, Çanakkale 17100, Türkiye.
Pharmaceuticals (Basel, Switzerland)
|February 27, 2026
概括
银纳米粒子 (AgNPs) 通过各种机制显示出显著的抗癌潜力. 然而,像毒性和临床翻译等挑战需要进一步的研究和优化策略.
科学领域:
- 纳米医学是一种纳米医学.
- 生物技术是生物技术.
- 癌症研究 癌症研究
背景情况:
- 银纳米粒子 (AgNPs) 具有多种生物活性,包括抗菌,抗氧化,抗炎和抗癌性质.
- 有证据表明,AgNP通过氧化应激,线粒体功能障碍,DNA损伤,细胞循环停止和亡产生抗癌作用.
- 抑制特定的细胞通路是AgNP抗癌活性的另一个关键机制.
研究的目的:
- 审查和综合最近发现的银纳米颗粒的抗癌潜力.
- 为提供AgNP抗癌活性背后的机制的全面概述.
- 讨论AgNP在癌症治疗中的临床转化所面临的挑战和未来战略.
主要方法:
- 对AgNP及其抗癌作用的体内和体外研究的文献综述.
- 对各种作用机制的分析,包括细胞损伤和途径抑制.
- 对绿色合成的AgNP进行评估,以提高生物相容性和选择性细胞毒性.
主要成果:
- 通过多种细胞和分子机制,AgNP表现出显著的抗癌作用.
- 绿色合成的AgNP显示出改善的生物相容性和对癌细胞的选择性毒性.
- 像大小/形状优化和表面功能化等策略可以提高有效性并减少毒性.
结论:
- 作为抗癌剂,AgNP具有相当大的前景,通过多种机制起作用.
- 解决AgNP毒性,非特异性损害和长期安全性对于临床应用至关重要.
- 需要进一步的研究和战略优化来克服挑战,并推进基于AgNP的癌症疗法.
相关概念视频
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:49Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
01:46Electron Transport Chain: Complex I and II
19.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.2K